Back

Levosimendan - single center experience in chronic HF

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 4 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joana Brito

Santa Maria University Hospital CHLN Lisbon Academic Medical Centre, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Evolution of patients with advanced heart failure with ambulatory intermitent infusions of long-term Levosimendan
Doctor A. Diaz Exposito (Malaga, ES)
Abstract Slides
Presentation thumbnail
Switching to Sacubitril/Valsartan during first weeks. Could we do better?
Mr A. Grande Trillo (Seville, ES)
Abstract Slides
Presentation thumbnail
Effect of sodium-glucose co-transporter-2 inhibitors in haemoglobin level of patients with heart failure with reduced ejection fraction
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides
Presentation thumbnail
Safety and efficacy of sildenafil in patients with advanced heart failure.
Assistant Professor I. Malek (Prague, CZ)
Abstract Slides
Presentation thumbnail
Initial experience of early post-discharge assessment in patients with heart failure and reduced ejection fraction
Mr A. Adeba Garcia (Oviedo, ES)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy 4

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources